[EN] PROTEASE INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS<br/>[FR] INHIBITEURS DE LA PROTÉASE POUR LE TRAITEMENT D'INFECTIONS À CORONAVIRUS
申请人:SCRIPPS RESEARCH INST
公开号:WO2022261473A1
公开(公告)日:2022-12-15
The application relates to compounds of Formula (I) and (III), their pharmaceutically acceptable salts, and their pharmaceutical compositions. The compounds are potent inhibitors of the main protease (Mpro) of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), and they are useful in treating or preventing COVID-19 in a subject.